The Heart Failure Policy Summit is an online event dedicated to the heart failure policy and advocacy community. It aims to facilitate peer learning among national heart failure advocates and empower them to engage decision-makers in their respective countries. The summit brings together patient advocates, healthcare professionals, clinical leaders, policymakers and other key figures in system transformation.
The Heart Failure Policy Network hosted its inaugural summit from 16 to 18 November 2021. The event framed heart failure alongside major policy debates (including health inequalities and COVID-19 recovery plans), showcased change leaders in heart failure policy, and highlighted priority topics for heart failure care in 2021 and beyond.
The summit delivered six sessions across three overarching themes:
The COVID-19 pandemic has created a ‘new normal’, but what does this mean for heart failure and cardiovascular disease care? As governments across Europe prepare and launch their national recovery plans, how can we ensure they consider the interests of the heart failure and cardiovascular disease communities, and meet their needs?
Chaired by: Billy Kelleher MEP (Member of the European Parliament, Renew Europe Group; former National Spokesperson on Health, Fianna Fáil, Ireland)
The European Union (EU) could become a powerful platform to advance research efforts, exchange best practices and raise awareness of heart failure among national decision-makers. Following growing calls for an EU Action Plan on Cardiovascular Disease and the launch of new EU funding programmes, how can advocates seize this opportunity to come together and direct much-needed resources towards cardiovascular research, innovation and care?
Chaired by: Ed Harding (Network Director, Heart Failure Policy Network; Managing Director, The Health Policy Partnership)
Diagnosing heart failure and detecting how and when the syndrome worsens remains a persistent challenge for health systems across Europe. As European guidelines shift towards a more person-centred and reactive approach to heart failure care, will our health systems be able to keep up?
Chaired by: Dr Joe Gallagher (Clinical Lead for Global Health and Cardiovascular, Irish College of General Practitioners)
Digital innovation could help to drive person-centred care by offering new delivery models to facilitate multidisciplinary working and data sharing, as well as patient involvement and self-care. The COVID-19 pandemic has accelerated the implementation of digital solutions – can we use this momentum to make person-centred care a reality for all?
Chaired by: Marc Bains (Co-Founder and Vice-President, HeartLife Foundation)
The existing heart failure workforce is under intense pressure and it is highly likely that in many countries, some form of clinical delegation will be needed to ensure equitable access to best-practice heart failure care. How can advocates build a case for decision-makers to invest in a specialist and expanded workforce?
Chaired by: Professor Izabella Uchmanowicz (President-Elect, European Society of Cardiology Association of Cardiovascular Nursing & Allied Professions, ACNAP)
In the past six years, the Heart Failure Policy Network (HFPN) has developed many policy materials to support heart failure advocates in engaging decision-makers, detailing what they should be asking for and why.
In this session, we explored how advocates can best engage decision-makers (by learning from successful initiatives) and examined what the HFPN should do to support advocates in 2022 and beyond.
Chaired by: Neil Johnson (Executive Director, Global Heart Hub; Chief Executive, Croí Heart & Stroke)
The 2021 Heart Failure Policy Summit is sponsored by AstraZeneca, Vifor Pharma, Bayer AG and Boehringer Ingelheim. Sponsors have provided input to the summit’s agenda, which was developed by the HFPN Secretariat. Full editorial control of all summit materials and sessions (including speaker management) lies with the HFPN Secretariat, guided by the Steering Committee and Summit Project Advisory Group.